Your browser doesn't support javascript.
loading
Response to: Note the distinction between myocarditis, novel coronavirus myocarditis and COVID-19 vaccine-associated myocarditis.
Awaya, T; Koizumi, T; Enomoto, Y; Moroi, M; Nakamura, M.
Affiliation
  • Awaya T; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Koizumi T; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Enomoto Y; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Moroi M; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
  • Nakamura M; From the Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo 153-8515, Japan.
QJM ; 115(10): 696, 2022 10 25.
Article in En | MEDLINE | ID: mdl-34791457
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: Country of publication: